AstraZeneca and Johnson and Johnson clinical vaccine trials resume

United States // 23 October, 2020

AstraZeneca and Johnson & Johnson will both resume their phase 3 clinical trials for their vaccines in the United States. AstraZenca's study was put on hold in September, just a few days after it started, due to a spinal cords injury reported in a British trial participant. The company stated that the U.S. Food and Drug Administration (FDA) had reviewed all safety data from trials globally and concluded it was safe to resume the trial. Johnson & Johnson's was halted on 12 October following an "injury" reported in a participant. The company announced today that there was no evidence the injury was caused by the vaccine.

LATEST NEWS

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. …
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. …